This inventor holds 1 USPTO granted patent. Top assignee: Kainos Medicine Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hanyang Cho: Innovator in Pharmaceutical Compounds
Introduction
Hanyang Cho is a notable inventor based in Seongnam, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of novel compounds. His work focuses on creating effective treatments for diseases mediated by IRAK-4 receptors.
Latest Patents
Hanyang Cho holds a patent for the compound N-(1H-imidazol-2-yl)benzamide. This compound, along with its pharmaceutically acceptable salts, prodrugs, solvates, or stereoisomers, exhibits excellent inhibitory activity against IRAK-4. It is particularly promising for the prevention and treatment of autoimmune diseases and lymphomas, offering a potential solution without side effects.
Career Highlights
Hanyang Cho is currently associated with Kainos Medicine Inc., where he continues to advance his research in pharmaceutical compositions. His dedication to innovation has positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Hanyang Cho collaborates with talented individuals such as Jaeuk Chung and Sunmi Kim. Their combined expertise enhances the research efforts at Kainos Medicine Inc., fostering an environment of innovation and discovery.
Conclusion
Hanyang Cho's contributions to the field of pharmaceuticals through his patent on N-(1H-imidazol-2-yl)benzamide highlight his role as an influential inventor. His work not only advances medical science but also holds the potential to improve patient outcomes in treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile